Holen Sie sich die Stockscreener-App
1.76
2.22%
-0.04
Finanzdaten der Nautilus Biotechnology Inc-Aktie (NAUT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Operating Expenses
|
8.03%
21.61
|
20.00 | 19.07 | 19.02 | 18.06 |
| Nonoperating Income/Loss |
3.36%
2.877
|
2.977 | 3.197 | 3.208 | 3.095 |
| Income/Loss From Continuing Operations Before Tax |
10.02%
-18.73
|
-17.02 | -15.88 | -15.81 | -14.96 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
10.02%
-18.73
|
-17.02 | -15.88 | -15.81 | -14.96 |
|
Net Income/Loss
|
10.02%
-18.73
|
-17.02 | -15.88 | -15.81 | -14.96 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
564.36K%
125.14
|
0.0222 | 124.93 | 124.60 | 124.59 |
| Diluted Average Shares |
564.36K%
125.14
|
0.0222 | 124.93 | 124.60 | 124.59 |
| Basic Earnings Per Share |
7.14%
-0.15
|
-0.14 | -0.13 | -0.13 | -0.12 |
| Diluted Earnings Per Share |
7.14%
-0.15
|
-0.14 | -0.13 | -0.13 | -0.12 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):